Cargando...
PD-L1 and Emerging Biomarkers in PD-1/PD-L1 Blockade Therapy
PD-(L)1 checkpoint blockade is revolutionizing cancer therapy, and biomarkers capable of predicting which patients are most likely to respond are highly desired. The detection of PD-L1 protein expression by immunohistochemistry can enrich for response to anti-PD-(L)1-blockade in a variety of tumor t...
Gardado en:
| Publicado en: | Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5830145/ https://ncbi.nlm.nih.gov/pubmed/29360727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000301 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|